<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    CohBar, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About CohBar, Inc.

    CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepatitis (NASH), obesity, Type 2 diabetes (T2D), cancer, cardiovascular disease and CNS disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Steven B. Engle, M.S.
    • FOUNDED
      2007
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Rubius Therapeutics, Inc.

    Rubius Therapeutics, Inc.

    Rubius Therapeutics developed our proprietary RED PLATFORMÂŽ to generate red blood...

    Rubius Therapeutics developed our proprietary R...

    Filing Type:    PU
    Bellerophon Therapeutics, Inc.

    Bellerophon Therapeutics, Inc.

    At Bellerophon Therapeutics, we aim to transform the lives of people suffering fro...

    At Bellerophon Therapeutics, we aim to transfor...

    Filing Type:    PU
    Scopus BioPharma Inc.

    Scopus BioPharma Inc.

    Scopus BioPharma develops small molecule therapeutics leveraging world-class exper...

    Scopus BioPharma develops small molecule therap...

    Filing Type:    RA
    IDEAYA Biosciences, Inc.

    IDEAYA Biosciences, Inc.

    IDEAYA is an oncology-focused precision medicine company committed to the discover...

    IDEAYA is an oncology-focused precision medicin...

    Filing Type:    PU
    Dicerna Pharmaceuticals, Inc.

    Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of...

    Dicerna is a biopharmaceutical company focused ...

    Filing Type:    PU
    Corvus Pharmaceuticals, Inc.

    Corvus Pharmaceuticals, Inc.

    Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company. We ...

    Corvus Pharmaceuticals is a clinical science-dr...

    Filing Type:    PU
    Fate Therapeutics, Inc.

    Fate Therapeutics, Inc.

    We are a biopharmaceutical company dedicated to the development of programmed cell...

    We are a biopharmaceutical company dedicated to...

    Filing Type:    PU
    Inovio Pharmaceuticals, Inc.

    Inovio Pharmaceuticals, Inc.

    Inovio is bringing IMMUNO-INGENUITY™ to life and is reshaping the future of trea...

    Inovio is bringing IMMUNO-INGENUITY™ to life ...

    Filing Type:    PU
    Genomic Health, Inc.

    Genomic Health, Inc.

    Genomic Health, Inc. (NASDAQ: GHDX) is the world's leading provider of genomic-bas...

    Genomic Health, Inc. (NASDAQ: GHDX) is the worl...

    Filing Type:    PU
    Beta Bionics, Inc.

    Beta Bionics, Inc.

    Beta Bionics develops an integrated bionic pancreas system called the iLet.

    Beta Bionics develops an integrated bionic panc...

    Amount Raised:    $126,600,000
    Fundraising Status:    SB
    Filing Type:    CF
    Immuron Limited

    Immuron Limited

    Immuron Ltd is a publicly listed Australian biopharmaceutical company focused on o...

    Immuron Ltd is a publicly listed Australian bio...

    Filing Type:    PU
    Insulet Corporation

    Insulet Corporation

    Insulet Corporation is an innovative medical device company based in Acton, Massac...

    Insulet Corporation is an innovative medical de...

    Filing Type:    PU
    PLx Pharma Inc.

    PLx Pharma Inc.

    PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage specialty pharmaceutical company i...

    PLx Pharma Inc. (Nasdaq: PLXP), is a late-stage...

    Filing Type:    PU
    BioCardia, Inc.

    BioCardia, Inc.

    BioCardia, Inc., headquartered in San Carlos, California, is developing regenerati...

    BioCardia, Inc., headquartered in San Carlos, C...

    Filing Type:    PU
    ShockWave Medical, Inc.

    ShockWave Medical, Inc.

    Shockwave Medical, headquartered in Santa Clara, California is a medical device co...

    Shockwave Medical, headquartered in Santa Clara...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.